Nov 2, 2012 06:44AM Piper Jaffray Upgrades Watson Pharmaceuticals (WPI) to Overweight
Jul 10, 2012 03:19PM Analysts Defend Questcor (QCOR) On Free-Fall In Shares
Jun 11, 2012 07:57AM Piper Jaffray Downgrades Watson Pharmaceuticals (WPI) to Neutral
Jan 25, 2012 11:09AM Notable Analyst Rating Changes 01/25: (WPI) (ALU) (TEX) Upgraded; (MS) (MTG) (NVDA) Downgraded
Jan 23, 2012 09:33AM Watson Pharmaceutical (WPI) volatility at 33 into FDA declining to recommend Prochieve
Nov 5, 2010 10:11AM Watson Pharma (WPI) Receives Upgrades, PT Boosts from Piper and UBS
Jul 19, 2010 02:41PM Piper Jaffray Specialty Pharma 2Q10 Preview: Street Estimates Sufficiently Conservative to Beatable
Jul 16, 2010 09:22AM Piper Jaffray Upgrades Watson Pharmaceuticals (WPI) to Neutral Amid Better Visibility on Long-Term Growth
Dec 10, 2009 04:38PM Piper Jaffray Initiates Coverage on Watson Pharmaceuticals (WPI) with an Underweight; Hard to Envision Significant Organic Growth